Donald G. Payan, EVP, President Discovery&Research at RIGEL PHARMACEUTICALS INC (RIGL), sold 5,303 shares at $4.00 ($21K) on 2016-08-30, disclosed to the SEC on 2016-09-01.
Scheduled sale ($21k) by EVP, President Discovery&Research under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RIGL | SELL | 2014-02-26 | $74K | — | Filing → |
| RIGL | SELL | 2012-06-20 | $87K | — | Filing → |